1-18 of 18
Sorin Visanica
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry

Thibault Comont, Maud D'Aveni, Laurence Schenone, Jose Miguel Torregrosa-Díaz, Lorea Aguinaga, Juan Pardo, Marie Sebert, Sorin Visanica, Clemence Santana, Lenaig Le Clech, Aspasia Stamatoullas, Sylvain Thepot, Etienne Daguindau, Guillaume Beziat, Teresa Botin, Sophie Dimicoli, Sophie Park, Etienne Paubelle, Bohrane Slama, Lise Willems, Houria Debarri, Emmanuel Gyan, Claire Calmettes, Odile Rauzy, Fatiha Chermat, Michaela Fontenay, Lionel Ades, Pierre Fenaux
Journal: Blood
Blood (2023) 142 (Supplement 1): 6471.
https://doi.org/10.1182/blood-2023-177787
Published: 2023
Journal Articles

Preliminary Study of Ruxolitinib and Venetoclax for Treatment of Patients with T-Cell Prolymphocytic Leukemia Refractory to, or Ineligible for Alemtuzumab

Charles Herbaux, Stéphanie Poulain, Damien Roos-Weil, Jacques-Olivier Bay, Yann Guillermin, Francois Lemonnier, Kamel Laribi, Sorin Visanica, Jerome Moreaux, Hugo Gonzalez, Maxime Jullien, Abderrazak El Yamani, Houria Debarri, Sophie Godet, Franck Morschhauser, Olivier Tournilhac, Matthew S. Davids, Loic Ysebaert
Journal: Blood
Blood (2021) 138 (Supplement 1): 1201.
https://doi.org/10.1182/blood-2021-149228
Published: 2021
Journal Articles

Updated Results from an Open-Label, Multicenter, Expanded Treatment Protocol (ETP) Phase (Ph) 3b Study of Ruxolitinib (RUX) in Patients (Pts) with Polycythemia Vera (PV) Who Were Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatment (Tx) Was Available

Lynda Foltz, MD FRCPC, Gian-Matteo Pica, MD, Hacene Zerazhi, Jan Van Droogenbroeck, MD, Sorin Visanica, MD, Enrique Báez de la Fuente, MD, Brian Leber, MD, Antonio Medina de Almeida, MD PhD, Dana Ranta, MD, Mauricio Reyes Cartes, MD, Jean-Jacques Kiladjian, MD PhD, Linda Chrit, PhD, Zhaoyu Yin, PhD, Juliane Morando, MD, Timothy Devos
Journal: Blood
Blood (2018) 132 (Supplement 1): 1774.
https://doi.org/10.1182/blood-2018-99-111479
Published: 2018
Journal Articles

Safety and Efficacy of Ruxolitinib (rux) in an Open-Label, Multicenter, Expanded Treatment Protocol in Patients (Pts) with Polycythemia Vera (PV) Who Are Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatments Are Available

Timothy Devos, MD, Gian Matteo Pica, MD, Hacene Zerazhi, Jan Van Droogenbroeck, Sorin Visanica, Enrique Báez de la Fuente, Brian Leber, MD, Antonio Medina de Almeida, MD PhD, Dana Ranta, Tomasa Martinez, Jean-Jacques Kiladjian, MD PhD, Linda Chrit, Zhaoyu Yin, Julian Perez Ronco, Lynda Foltz
Journal: Blood
Blood (2017) 130 (Supplement 1): 2918.
https://doi.org/10.1182/blood.V130.Suppl_1.2918.2918
Published: 2017
Journal Articles

Personalized Daily Doses of Imatinib By Therapeutic Drug Monitoring Increase the Rates of Molecular Responses in Patients with Chronic Myeloid Leukemia. Final Results of the Randomized OPTIM Imatinib Study

Philippe Rousselot, MD PhD, Hyacinthe Johnson-Ansah, MD, Françoise Huguet, MD, Laurence Legros, MD, Martine Escoffre-Barbe, Martine Gardembas, MD, Pascale Cony-Makhoul, MD, Valérie Coiteux, MD, Laurent Sutton, MD, Wajed Abarah, MD, Camille Pouaty, MD, Jean Michel Pignon, MD, Bachra Choufi, MD, Sorin Visanica, MD, Bénédicte Deau, MD, Stephane Bouchet, MDPhD, Francois Guilhot, MD, Francois-Xavier Mahon, MD PhD Professor, Laure Morisset, Jean-Michel Cayuela, Benjamin Maneglier, MD
Journal: Blood
Blood (2015) 126 (23): 133.
https://doi.org/10.1182/blood.V126.23.133.133
Published: 2015
Journal Articles

The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

Mathilde Lamarque, Sophie Raynaud, Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne Rauzy, Pascal Turlure, Norbert Vey, Christian Recher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Sorin Visanica, Aspasia Stamatoullas, Pierre Fenaux, Lionel Adès
Journal: Blood
Blood (2012) 120 (25): 5084–5085.
https://doi.org/10.1182/blood-2012-09-453555
Published: 2012
Journal Articles

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

Annalisa Andreoli, MD, Jerome Rey, MD, Charles Dauriac, MD, Raoul Herbrecht, MD, Franck E. Nicolini, MD, PhD, Christian Recher, MD, PhD, Philippe Rousselot, MD, PhD, Jacques Delaunay, MD, Bernard Drenou, MD, PhD, Dana Ranta, MD, Laurence Legros, MD, PhD, Martine Delain, MD, Pascale Cony-Makhoul, MD, Jean-François Viallard, MD, PhD, Sorin Visanica, MD, Sophie Lefort, MD, Brigitte Dupriez, MD, Valérie Coiteux, MD, Denis Guyotat, MD, Borhane Slama, MD, Khaled Benabed, MD, Jean-Loup Demory, MD, Stephane Giraudier, MD, PhD, Damien Roos-Weil, MD, Laurence Sanhes, MD, Anne Quinquenel, MD, Pascal Lenain, MD, Valérie Ugo, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Lydia Roy, MD
Journal: Blood
Blood (2012) 120 (21): 2841.
https://doi.org/10.1182/blood.V120.21.2841.2841
Published: 2012
Journal Articles

Revised-IPSS (IPSS-R) Is a Powerful Tool to Evaluate the Outcome of MDS Patient Treated with Azacitidine (AZA): The Groupe Francophone Des Myelodysplasies (GFM) Experience

Lionel Ades, MD, PhD, Mathilde Lamarque, MD, Sophie Raynaud, Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, MD, PhD, Francois Dreyfus, Odile Beyne Rauzy, MD, PhD, Pascal Turlure, MD, Norbert Vey, MD, Christian Recher, MD, Caroline Dartigeas, MD, Laurence Legros, MD, PhD, Jacques Delaunay, MD, Sorin Visanica, Aspasia Stamatoullas, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 422.
https://doi.org/10.1182/blood.V120.21.422.422
Published: 2012
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012
Journal Articles

Impact of the Provisional Revised-IPSS (R-IPSS) in 265 MDS Patients Treated with Azacitidine (AZA): The Groupe Francophone Des Myelodysplasies (GFM) Experience

Mathilde Lamarque, MD, Sophie Raynaud, Raphael Itzykson, MD, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne Rauzy, Pascal Turlure, Norbert Vey, MD, Christian Recher, MD, PhD, Caroline Dartigeas, MD, Laurence Legros, Jacques Delaunay, Sorin Visanica, Aspasia Stamatoullas, Pierre Fenaux, MD, PhD, Lionel Ades
Journal: Blood
Blood (2011) 118 (21): 972.
https://doi.org/10.1182/blood.V118.21.972.972
Published: 2011
Journal Articles

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Clinical Trials & Observations
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Norbert Vey, Christian Recher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Célia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Francoise Isnard, Anne Marfaing-Koka, Stephane de Botton, Youcef Chelghoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, C. L. Beach, Lionel Adès, Pierre Fenaux, on behalf of the Groupe Francophone des Myelodysplasies (GFM)
Journal: Blood
Blood (2011) 117 (2): 403–411.
https://doi.org/10.1182/blood-2010-06-289280
Published: 2011
Journal Articles

A Prognostic Score for Overall Survival (OS) with Azacitidine (AZA) In Higher Risk MDS Based on 282 Patients (pts), and Validated In 175 Pts From the AZA 001 Trial

Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Christian Recher, Caroline Dartigeas, Norbert Vey, MD, Laurence Legros, Jacques Delaunay, Celia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, MD, Anne Marfaing-Koka, Stephane De Botton, Youcef Chelgoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, CL Beach, PharmD, Lionel Ades, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3996.
https://doi.org/10.1182/blood.V116.21.3996.3996
Published: 2010
Journal Articles

Risk of AML Evolution In Lower Risk MDS with Del 5q Treated with or without Lenalidomide. A Report by the Groupe Francophone Des Myelodysplasies (GFM)

Lionel Ades, Fabien Lebras, Marie Sebert, Charikleia Kelaidi, Thierry Lamy, Francois Dreyfus, Jacques Delaunay, Sorin Visanica, Pascal Turlure, MD, Agnes Guerci, Marie Paule Cabrol, Anne Banos, Michel Blanc, Norbert Vey, Virginie Eclache, Sylvie Chevret, Pierre Fenaux
Journal: Blood
Blood (2010) 116 (21): 976.
https://doi.org/10.1182/blood.V116.21.976.976
Published: 2010
Journal Articles

Azacytidine in Refractory or Relapsed AML After Intensive Chemotherapy (IC): Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Christian Recher, Jacques Delaunay, MD, Bruno Quesnel, Francois Dreyfus, MD, PhD, Anne Marfaing Koka, Norbert Vey, Aspasia Stamatoullas, Emmanuel Gyan, MD, Thomas Cluzeau, Philippe Rousselot, MD, PhD, Oumedaly Reman, Isabelle Plantier, Jean Pierre Marolleau, MD, Pierre Morel, MD, Eric Wattel, MD, PhD, Sorin Visanica, MD, Chahinez Zerhouni, Dominique Bordessoule, Lionel Ades, MD, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2009) 114 (22): 1054.
https://doi.org/10.1182/blood.V114.22.1054.1054
Published: 2009
Journal Articles

Prognostic Factors of Response and Overall Survival (OS) in Higher-Risk MDS (including RAEB-t) Treated with Azacytidine (AZA): Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Odile Beyne-Rauzy, MD, PhD, Francois Dreyfus, MD, PhD, Norbert Vey, MD, Pascal Turlure, MD, Laurence Legros, Caroline Dartigeas, Jacques Delaunay, MD, Stephane de Botton, MD, PhD, Emmanuel Raffoux, MD, Anne-Laure Taksin, MD, Aspasia Stamatoullas, Anne Marfaing Koka, Eric Wattel, MD, PhD, Sorin Visanica, MD, Célia Salanoubat, Pierre Morel, MD, Pascale Cony Makhoul, Stéphane Cheze, Laurence Sanhes, Isabelle Plantier, Gerard Tertian, Mehdi Dahoun, Agnes Guerci, MD, PhD, Claude Gardin, Lionel Ades, MD, Pierre Fenaux
Journal: Blood
Blood (2009) 114 (22): 3820.
https://doi.org/10.1182/blood.V114.22.3820.3820
Published: 2009
Journal Articles

Treatment of Lower Risk MDS with Del 5q with Lenalidomide (LEN): Results of the French ATU Program.

Fabien Le bras, MD, Marie Sebert, MD, Charikleia Kelaidi, MD, Thierry Lamy, MD, PhD, Francois Dreyfus, MD, PhD, Jacques Delaunay, MD, Anne Banos, MD, Michel Blanc, MD, Norbert Vey, MD, PhD, Martine Gardembas, MD, Sorin Visanica, MD, Frederic Bauduer, MD, Pascal Turlure, MD, Mehdi Dahoun, Odile Beyne-Rauzy, MD, PhD, Agnes Guerci, MD, PhD, Alain Delmer, MD, PhD, Stephane de Botton, MD, PhD, Christian Berthou, MD, Caroline Besson, MD, Delphine Rea, MD, PhD, Francois Lefrere, MD, Eric Wattel, MD, PhD, Philippe Rousselot, MD, PhD, Pierre Fenaux, MD, PhD, Lionel Ades, MD
Journal: Blood
Blood (2009) 114 (22): 2764.
https://doi.org/10.1182/blood.V114.22.2764.2764
Published: 2009
Journal Articles

CALM-AF10 Positive Acute Myeloid Leukemias: A French Cohort of 18 Patients.

Cecile Borel, Nicole Dastugue, Thomas Prebet, MD, Norbert Vey, MD, Marie-Joelle Mozziconacci, Christian Bastard, Christine Lefebvre, Francine Mugneret, Dominique Leroux, Faezeh Legrand, Marie Agnes Collonges Rame, Sorin Visanica, Jean Philippe Rault, Nathalie Gachard, Arnaud Pigneux, MD, PhD, Eric Lippert, Sylvie Taviaux, Pascaline Talmant, Murielle Roussel, Françoise Huguet, Eric Delabesse, PhD, Christian Recher
Journal: Blood
Blood (2008) 112 (11): 1496.
https://doi.org/10.1182/blood.V112.11.1496.1496
Published: 2008
Journal Articles

Treatment of Lower Risk MDS with Del 5q by Lenalidomide, with or without G-CSF: Current Results of the French Patient Named Program (ATU)

Fabien Lebras, Marie Sebert, Virginie Eclache, Thierry Lamy, Jacques Delaunay, Sorin Visanica, Francois Dreyfus, Anne Banos, Michel Blanc, Caroline Besson, Xavier Thomas, Philippe Rodon, Norbert Vey, Martine Gardembas, Frederic Bauduer, MD, Jean-Francois Ramee, Alain Delmer, Delphine Rea, Pascal Turlure, Odile Beyne-Rauzy, Agnes Guerci, Joel Ceccaldi, J. Dugay, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2008) 112 (11): 5069.
https://doi.org/10.1182/blood.V112.11.5069.5069
Published: 2008